Hot Features
Premium
Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Período:
Tipo de Línea:
| Volume | 77,073 |
|
|||||
| Noticias | - | ||||||
| Máximo del Dia | 12.40 | Mínimo Máximo |
|||||
| Minimo del Dia | 11.604 | ||||||
| Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
|---|---|---|---|
| Pulse Biosciences Inc | PLSE | NASDAQ | Acción Común |
| Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora
|
|
|---|---|---|---|---|
| -0.17 | -1.39% | 12.03 | 19:00:00 |
| Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
|---|---|---|---|---|
| 11.97 | 11.604 | 12.40 | 12.03 | 12.20 |
| Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
|---|---|---|---|---|---|
| 1,633 | 77,073 | US$ 12.04 | US$ 927,928 | - | 3.78 - 14.96 |
| Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
|---|---|---|---|---|
| 15:05:06 | priorref | 3,000 | US$ 12.03 | USD |
Información Financiera Pulse Biosciences Inc PLSE
| Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
|---|---|---|---|---|---|---|
| 663.2M | 54.99M | - | 0 | -42.21M | -0.77 | - |
| Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
|---|---|---|---|---|---|
| - | - | - | - |
Noticias sobre Pulse Biosciences Inc PLSE
| Fecha | Hora | Fuente | Noticias Artículo |
|---|---|---|---|
| 07/6/2024 | 15:16 | Edgar (US Regulatory) | Form 8-K - Current report |
| 04/6/2024 | 15:05 | Edgar (US Regulatory) | Form 424B2 - Prospectus [Rule 424(b)(2)] |
| 04/6/2024 | 15:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 02/6/2024 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 31/5/2024 | 15:18 | Edgar (US Regulatory) | Form SD - Specialized disclosure report |
| 28/5/2024 | 16:19 | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration.. |
| 22/5/2024 | 13:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 22/5/2024 | 13:03 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 20/5/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 20/5/2024 | 15:05 | Business Wire | Pulse Biosciences Announces Updated Timing of Rights.. |
| 16/5/2024 | 07:00 | Business Wire | Pulse Biosciences’ CellFX Nanosecond Pulsed Field Ablation.. |
| 15/5/2024 | 08:05 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos PLSE
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 14.23 | 14.54 | 11.604 | 12.83 | 243,622 | -2.20 | -15.46% |
| 1 Month | 7.92 | 14.96 | 7.60 | 12.40 | 317,998 | 4.11 | 51.89% |
| 3 Months | 9.43 | 14.96 | 6.595 | 9.82 | 225,742 | 2.60 | 27.57% |
| 6 Months | 10.37 | 14.96 | 6.595 | 9.98 | 225,584 | 1.66 | 16.01% |
| 1 Year | 6.73 | 14.96 | 3.78 | 8.39 | 215,929 | 5.30 | 78.75% |
| 3 Years | 17.63 | 29.16 | 1.18 | 7.29 | 162,162 | -5.60 | -31.76% |
| 5 Years | 12.55 | 45.82 | 1.18 | 9.79 | 133,167 | -0.52 | -4.14% |
